INNOVATIVE EYEWEAR INC (LUCY)
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
$0.93+2.73%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
QuarterlyIQ Insights · LUCY
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
No current thesis-health read is available for this company.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -81.1% |
| Our one-year growth estimate | diamond | 100.0% |
Growth built into the price is above our model estimate.
The price assumes 181.1 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Model as of 2026-09-04 · Compared with 25 industry peers · Company calendar date is not available
LUCY — capital allocation — The New Warrants, PA Warrants, New Warrant Shares, and PA Warrant Shares are…
Dated 2026-07-09
The New Warrants, PA Warrants, New Warrant Shares, and PA Warrant Shares are being sold and issued without registration under the Securities Act, in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act as a transaction not involving a public offering and Rule 506 promulgated under the Securities Act as sales to accredited investors, and in reliance on similar exemptions under applicable state laws. Such securities may not be offered or sold in the United States absent…
Why it matters: Improving gross profit is crucial for reducing net losses. It shows better cost management.
Supportive ifGross profit for Q2 2026 is more than $175,445. This shows better cost control.
Worry ifGross profit remains below $175,445, showing ongoing cost issues.
Why it matters: Updates on capital use show how well the company manages its money. This is important for investor trust.
Watch forManagement gives a clear update on capital use plans and warrant deals.
Also watch forNo updates or negative comments on capital use plans.
Why it matters: The earnings report will show updates on revenue and profit. Investors want to see if things are getting better or if losses continue.
Watch forThe company announces a specific date for its next earnings report.
Also watch forThe company delays or cancels the earnings report without a new date.
Why it matters: Revenue growth is key to reaching the $2.7 million target for 2025. It shows the company's ability to scale.
Supportive ifQ2 2026 revenue shows growth above 20% year over year.
Worry ifQ2 2026 revenue growth is below 10% year over year.
Why it matters: New agreements can show chances for growth. They may improve market position.
Supportive ifThere is a new partnership or acquisition that helps expand market reach.
Worry ifNo new M&A activity or bad news about the recent agreement.
Why it matters: Better gross profit means improved cost management and higher product demand. This helps reduce net losses.
Supportive ifGross profit in Q3 shows a positive number, indicating strong sales and cost control.
Worry ifGross profit remains negative or declines from Q2 levels.
Why it matters: If the health care sector's revenue growth picks up, it could benefit Innovative Eyewear. This signals a stronger market environment.
Supportive ifHealth care sector revenue growth accelerates back toward 12% or higher.
Worry ifSector revenue growth remains below 9% for another quarter.
Why it matters: FOMC decisions can affect consumer spending, impacting sales of smart eyewear. This is important for revenue growth.
Watch forFOMC decisions lead to more spending by consumers. This means higher sales for the company.
Also watch forFOMC decisions lead to less spending by consumers. This means lower sales for the company.
Why it matters: Cutting net losses is important for the long term. It shows better financial health.
Supportive ifNet losses in Q2 2026 are reported below $2 million.
Worry ifNet losses in Q2 2026 remain above $2 million.
Why it matters: Achieving the revenue goal shows the company is on track with its growth strategy. It is a key measure of success.
Supportive ifQ3 revenue reaches or exceeds $2.7 million.
Worry ifQ3 revenue falls below $1.6 million.
Why it matters: Closing the warrant exercise will bring in $3 million for working capital. This supports growth plans.
Supportive ifThe deal will close on or before July 9, 2026. It will bring in $3 million.
Worry ifThe transaction does not close as planned, delaying the expected capital influx.
Why it matters: If the new Series J warrants are used, it could bring in an extra $7.25 million. This would help with financial flexibility.
Supportive ifMany Series J warrants are used in the first six months after they are issued.
Worry ifFew or no Series J warrants are used. This shows weak interest from investors.
Why it matters: Hitting this revenue target shows strong demand for smart eyewear. It also shows good growth strategies.
Supportive ifQuarterly revenue goes over $1 million soon. It is moving toward the $2.7 million target.
Worry ifQuarterly revenue stays below $1 million. This shows challenges in growing.
Why it matters: Higher gross profit margins show better cost management. They also show better pricing strategies.
Supportive ifGross profit margins improve a lot in the next quarterly report. This shows positive trends.
Worry ifGross profit margins decline or remain flat, suggesting ongoing cost issues.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$269 on $10,000 · ±2.7% | How much price usually moves either way. |
| Bad day | $881 loss on $10,000 · 8.8% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $6,959 loss on $10,000 · 69.6% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.